Hemorrhoid is a highly uncomfortable disorder which is also known as piles. The condition is so subtle yet dangerous that most people under the age of fifty are unaware of the same. Hemorrhoids are inflamed, swollen veins situated in the anal canal and causes a strong sense of irritation in the form of both pain and itchiness. Patients who suffer from the same condition seek relief from a variety of products, boasting both negatives and positives. Direct products like wipes, creams, pads, and suppositories are highly effective at offering temporary period of relief. However, it is not effective enough for permanent treatments.
Latest Free Sample Copy Available @
The prevalence of hemorrhoids is found particularly between the age of 45 and 65, both in men and women. However, only a small percentage of the affected population seek any form of medical treatment like medication or surgery and instead opt for relief pills purchased from pharmacies.
According to the latest report by the team of Market Research Future (MRFR), the global hemorrhoids treatment market Hemorrhoid Treatment Devices Market is expected to register a CAGR of 5.98% to reach USD 973.94 Million by 2025. The market growth is influenced by numerous factors like the increasing prevalence of lifestyle-based diseases, growing demand for treatment, an increasing demand for reducing infections & complications relating to hemorrhoids, and an increasing number of surgeries. The growing old-age population is also one of the key contributors to the global demand for hemorrhoids treatment. However, lack of awareness and hesitancy towards medical treatment due to the feeling of embarrassment stands out as a key constraint to the growth of the global market.
Market Segmentation
The global hemorrhoids treatment market segmentation is based in terms of route of administration, treatment type, distribution channel, and region.
By route of administration, the market divides into oral and topical agents.
By treatment type, the market segments into drugs, surgical procedures, and non-surgical procedures. The drugs segment is further segmented into NSAIDs, laxatives, and herbals. The non-surgical procedures narrows down into cryotherapy, band litigation, and sclerotherapy.
By distribution channel, the market includes hospital pharmacies, retail pharmacies, online pharmacies, and others.
Regional Analysis
The regional segmentation of the global hemorrhoids market covers four major regions globally, namely Asia Pacific, Europe, the Americas, and the Middle East & Africa.
The Americas hold the maximum share of the market as per the global standings. The dominance of the region can be attributed to the huge patient population, high expenditure in the healthcare sector, and a well-established technology. The regional market for hemorrhoids treatment is expected to continue its dominance in the forthcoming years.
Europe accounts for the second largest market globally following the Americas. The European region is segmented into key regions, namely Western and Eastern Europe. The Western European region consists of countries like the UK, Germany, and France. Factors that primarily push the market in this region are the lack of any physical exercise, sedentary lifestyle, obesity, alcoholism, poor fiber intake in diet, etc.
Asia Pacific is slated to be the fastest growing regions in hemorrhoids. The growth in this region can be attributed to factors like the increasing demand for better diagnostic devices, rapidly improving technologies, better and safe therapeutic approach, and the presence of a massive talent pool.
Competitive Landscape
The global hemorrhoids treatment market holds a number of key players like Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company, Abbott Laboratories, Boston Scientific Corporation, GlaxoSmithKline, Pfizer Inc., AstraZeneca PLC, CONMED Corporation, Taro Pharmaceuticals Inc., Astra Zeneca, Olympus Corporation, Cook Medical, Glenmark Pharmaceuticals Bayer AG, Teva Pharmaceutical Industries Ltd, and others.
13th March 2019, Organization de Scalene announced recently the launch of Cryocure. Cryocure is an affordable medical device that is used to treat piles without any need for surgery.
8th April 2019, Trifecta Pharmaceuticals, one of the leading developers, distributors, and manufacturers of specialty OTC topical creams, gels, and ointments announced today about its distribution partnership with Walmart. The move will see Mayinglong, a hemorrhoid treatment ointment, being available on the shelves of the leading departmental store.
Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/hemorrhoid-treatment-devices-market-8726
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
